Malaysia Analgesics Market Report: Trends, Growth and Forecast (2026-2032)
By Product (Systemic Analgesics (Adult Analgesics, Paediatric Analgesics, Combined Systemic Analgesics), Topical Analgesics/Anaesthetic), By Drug Type (Opioid Analgesics (Strong Opioids, Weak Opioids), Non-opioid Analgesics (Acetaminophen, Aspirin, Combination Products, Diclofenac, Dipyrone, Ibuprofen, Ketoprofen, Naproxen, OTC Triptans), Compound/Combination Analgesics (Opioid + Non-Opioid Combinations, Multi-Ingredient Non-Opioid Combinations)), By Route of Administration (Oral, Parenteral/Injectable, Topical/External, Transdermal, Rectal/Other), By Pain Type (Acute Pain, Chronic Pain, Breakthrough Pain), By Application (Surgical & Post-operative Pain, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Migraine/Headache, Dental Pain, Others), By Sales Channel (Retail Offline (Offline Pharmacies, Hospital Pharmacies), Retail Online (Online Pharmacies)), By Prescription Type (Prescription, OTC), By Formulation (Tablets, Capsules, Liquids, Injectables, Gels/Creams, Patches), By End User (Hospitals, Clinics/ASCs, Homecare)
|
Major Players
|
Malaysia Analgesics Market Statistics and Insights, 2026
- Market Size Statistics
- Analgesics market size in Malaysia was valued at USD 135 million in 2025 and is estimated at USD 140 million in 2026.
- The market size is expected to grow to USD 155 million by 2032.
- Market to register a CAGR of around 1.99% during 2026-32.
- Product Shares
- Topical analgesics/anaesthetic grabbed market share of 55%.
- Competition
- More than 20 companies are actively engaged in producing analgesics in Malaysia.
- Top 5 companies acquired around 65% of the market share.
- Taisho Pharmaceutical (M) Sdn Bhd, Rohto-Mentholatum (M) Sdn Bhd, Pharmaniaga Bhd, GlaxoSmithKline Consumer Healthcare Sdn Bhd, Tiger Balm (M) Sdn Bhd etc., are few of the top companies.
- Sales Channel
- Retail offline grabbed 70% of the market.
Malaysia Analgesics Market Outlook
Malaysia analgesics market size was valued at USD 135 million in 2025 and is projected to grow from USD 140 million in 2026 to USD 155 million by 2032, exhibiting a CAGR of 1.99% during the forecast period. The outlook remains steady as everyday pain relief continues to be part of regular self care, supported by recurring demand for products used for joint pain, back pain, muscle strain, menstrual pain, and post activity discomfort.
Demand is likely to stay supported by the country’s ageing population and active daily lifestyles. The share of people aged 65 and above rises from 7.6% in 2024 to 8.0% in 2025, while 12 states reach ageing state status in 2025. This keeps the need for practical pain relief visible across the country and supports regular use of analgesics that offer quick symptom control in daily life. At the same time, wider participation in exercise and recreation also strengthens demand for products used for cramps, sprains, and muscle pain.
Product preference is expected to remain focused on targeted formats, with topical analgesics/anaesthetic holding around 55% of value share. This segment stays ahead because consumers increasingly prefer easy to apply products that deliver fast localised relief. The stronger sports and recreation culture also supports this direction, as topical formats fit well with post sport recovery and everyday body pain management.
Sales are likely to remain led by physical stores, with retail offline accounting for around 70% of value share. Buyers still prefer pharmacies and health and beauty stores for quick access, immediate purchase, and trusted advice when choosing analgesic products. Even so, price sensitivity will stay important as repeated household purchases make consumers compare value more closely, while stronger digital access will continue to improve product discovery, promotions, and purchase decisions across the category.

Malaysia Analgesics Market Growth DriverAgeing Keeps Everyday Pain Relief Relevant
A growing older population supports analgesics demand in Malaysia. Older adults are more likely to face joint pain, back pain, and other recurring discomforts, which keeps everyday pain relief important in regular self care. This also supports continued use of familiar analgesic products that offer quick and practical symptom relief in daily life.
Department of Statistics Malaysia (DOSM)’s 2025 population estimates show that the share of people aged 65 and above rises from 7.6% in 2024 to 8.0% in 2025. DOSM also says 12 states have reached ageing state status in 2025, with Melaka, Pahang, and W.P. Kuala Lumpur joining the group. This age structure keeps pain management needs visible across the country.
Malaysia Analgesics Market ChallengeValue Pressure Strengthens Generic Competition
Price sensitivity remains a key challenge for analgesics in Malaysia. Pain relief products are bought regularly, so consumers notice price differences quickly and compare lower cost options more closely. This creates pressure on branded players, especially when local generic products remain affordable and buyers weigh value carefully in routine healthcare spending.
DOSM reports that Malaysia’s inflation increases 1.6% in December 2025 and 1.4% in February 2026 (latest release). Even with moderate inflation, repeated household purchases remain price sensitive, and value for money stays important in daily medicine buying. This makes it harder for higher priced analgesics to widen demand against cheaper alternatives.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Malaysia Analgesics Market TrendDigital Discovery Gains More Influence
A clearer trend in Malaysia is the stronger role of digital access in how consumers discover and compare analgesics. Buyers increasingly use online channels to check formats, promotions, and product details, which supports wider visibility for pain relief products and helps consumers make faster self care decisions.
DOSM states that retail online revenue by establishment records 1.3% annual growth in the third quarter of 2025. The same 2025 digital economy release says 94.0% of establishments have internet access and 72.7% have web presence. This stronger digital environment makes analgesics easier to promote and easier for consumers to discover.
Malaysia Analgesics Market OpportunityCommunity Sports Open New Room for Topical Relief
More community sports and active recreation create stronger room for pain relief products in Malaysia. As consumers take part in exercise and outdoor activities, the need for relief from strains, cramps, and post activity discomfort becomes more visible. This gives brands more space to expand topical formats that are easy to use and quick to apply.
The Ministry of Youth and Sports says the national Hari Sukan Negara 2025 celebration runs from 10 to 12 October 2025, records more than 10,000 attendees at the national level event, and features over 40 main sports and recreation activities, with hundreds more at state and district level. This wider sports culture supports stronger opportunity for topical pain relief solutions.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Malaysia Analgesics Market Segmentation Analysis
By Product
- Systemic Analgesics
- Adult Analgesics
- Paediatric Analgesics
- Combined Systemic Analgesics
- Topical Analgesics/Anaesthetic
The segment with the highest share under the product is topical analgesics/anaesthetic, holding around 55% of the Malaysia analgesics market in value terms. This segment stays ahead because consumers increasingly prefer targeted relief for muscle strain, back discomfort, menstrual pain, and post sport recovery. Easy application and fast localised action also make these products practical for daily use.
Its strong position is supported by Malaysia’s wider sports and recreation activity. The Ministry of Youth and Sports says Hari Sukan Negara 2025 records more than 10,000 attendees and features over 40 main sports and recreation activities, alongside hundreds more at state and district level. This broader activity culture supports demand for topical products used for sprains, cramps, and muscle pain.

By Sales Channel
- Retail Offline
- Offline Pharmacies
- Hospital Pharmacies
- Retail Online
- Online Pharmacies
The segment with the highest share under the sales channel is retail offline, accounting for around 70% of the Malaysia analgesics market in value terms. This channel leads because consumers still prefer physical pharmacies and health and beauty stores for quick access, immediate purchase, and trusted advice when choosing pain relief products, especially when relief is needed without waiting for delivery.
Retail offline also benefits from Malaysia’s pharmacy linked access system. The Ministry of Health’s Ubat@Komuniti service works with 45 community pharmacies, with 1,524 customers joining the pilot and 5,321 appointments fulfilled. This official expansion of community pharmacy touchpoints supports store based medicine access and helps keep offline buying central for analgesics.
List of Companies Covered in Malaysia Analgesics Market
The companies listed below are highly influential in the Malaysia analgesics market, with a significant market share and a strong impact on industry developments.
- Taisho Pharmaceutical (M) Sdn Bhd
- Rohto-Mentholatum (M) Sdn Bhd
- Pharmaniaga Bhd
- GlaxoSmithKline Consumer Healthcare Sdn Bhd
- Tiger Balm (M) Sdn Bhd
- Leung Kai Fook Medical (M) Sdn Bhd
- Kobayashi Pharmaceutical Co Ltd
- Hisamitsu Pharmaceutical Co Inc
- Winwa Medical Sdn Bhd
- Duopharma Biotech Bhd
Competitive Landscape
In 2025, analgesics in Malaysia recorded positive value growth, supported by consumers returning to active lifestyles and facing higher risks of injuries, stress-related headaches, and viral infections. GlaxoSmithKline Consumer Healthcare Sdn Bhd led the market with a 30.9% value share, followed by Tiger Balm (M) Sdn Bhd at 14.1%. Demand was driven by strong performance of acetaminophen and especially topical analgesics, which remained the largest and fastest-growing segment due to innovation in formats such as patches and sprays. Herbal and traditional products also gained traction, reflecting cultural preferences for natural remedies. Growth was further supported by rising awareness of self-medication and increasing availability of higher-dose formulations, while health and beauty specialist retailers remained the primary distribution channel, with e-commerce gradually gaining relevance through improved convenience and delivery options.
Frequently Asked Questions
Related Report
- Market Segmentation
- Research Scope
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Malaysia Analgesics Market Policies, Regulations, and Standards
- Malaysia Analgesics Market Dynamics
- Growth Factors
- Challenges
- Trends
- Opportunities
- Malaysia Analgesics Market Statistics, 2022-2032F
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Product
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Adult Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Combined Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Topical Analgesics/Anaesthetic- Market Insights and Forecast 2022-2032, USD Million
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Drug Type
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Strong Opioids- Market Insights and Forecast 2022-2032, USD Million
- Weak Opioids- Market Insights and Forecast 2022-2032, USD Million
- Non-opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Acetaminophen- Market Insights and Forecast 2022-2032, USD Million
- Aspirin- Market Insights and Forecast 2022-2032, USD Million
- Combination Products- Market Insights and Forecast 2022-2032, USD Million
- Diclofenac- Market Insights and Forecast 2022-2032, USD Million
- Dipyrone- Market Insights and Forecast 2022-2032, USD Million
- Ibuprofen- Market Insights and Forecast 2022-2032, USD Million
- Ketoprofen- Market Insights and Forecast 2022-2032, USD Million
- Naproxen- Market Insights and Forecast 2022-2032, USD Million
- OTC Triptans- Market Insights and Forecast 2022-2032, USD Million
- Compound/Combination Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Opioid + Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Multi-Ingredient Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration
- Oral- Market Insights and Forecast 2022-2032, USD Million
- Parenteral/Injectable- Market Insights and Forecast 2022-2032, USD Million
- Topical/External- Market Insights and Forecast 2022-2032, USD Million
- Transdermal- Market Insights and Forecast 2022-2032, USD Million
- Rectal/Other- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type
- Acute Pain- Market Insights and Forecast 2022-2032, USD Million
- Chronic Pain- Market Insights and Forecast 2022-2032, USD Million
- Breakthrough Pain- Market Insights and Forecast 2022-2032, USD Million
- By Application
- Surgical & Post-operative Pain- Market Insights and Forecast 2022-2032, USD Million
- Musculoskeletal Pain- Market Insights and Forecast 2022-2032, USD Million
- Neuropathic Pain- Market Insights and Forecast 2022-2032, USD Million
- Cancer Pain- Market Insights and Forecast 2022-2032, USD Million
- Migraine/Headache- Market Insights and Forecast 2022-2032, USD Million
- Dental Pain- Market Insights and Forecast 2022-2032, USD Million
- Others- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- Offline Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Hospital Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Online- Market Insights and Forecast 2022-2032, USD Million
- Online Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type
- Prescription- Market Insights and Forecast 2022-2032, USD Million
- OTC- Market Insights and Forecast 2022-2032, USD Million
- By Formulation
- Tablets- Market Insights and Forecast 2022-2032, USD Million
- Capsules- Market Insights and Forecast 2022-2032, USD Million
- Liquids- Market Insights and Forecast 2022-2032, USD Million
- Injectables- Market Insights and Forecast 2022-2032, USD Million
- Gels/Creams- Market Insights and Forecast 2022-2032, USD Million
- Patches- Market Insights and Forecast 2022-2032, USD Million
- By End User
- Hospitals- Market Insights and Forecast 2022-2032, USD Million
- Clinics/ASCs- Market Insights and Forecast 2022-2032, USD Million
- Homecare- Market Insights and Forecast 2022-2032, USD Million
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- By Product
- Market Size & Growth Outlook
- Malaysia Systemic Analgesics Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Malaysia Topical Analgesics/Anaesthetic Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Competitive Outlook
- Company Profiles
- GlaxoSmithKline Consumer Healthcare Sdn Bhd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Tiger Balm (M) Sdn Bhd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Leung Kai Fook Medical (M) Sdn Bhd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Kobayashi Pharmaceutical Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Hisamitsu Pharmaceutical Co Inc
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Taisho Pharmaceutical (M) Sdn Bhd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Rohto-Mentholatum (M) Sdn Bhd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Pharmaniaga Bhd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Winwa Medical Sdn Bhd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Duopharma Biotech Bhd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- GlaxoSmithKline Consumer Healthcare Sdn Bhd
- Company Profiles
- Disclaimer
| Segment | Sub-Segment |
|---|---|
| By Product |
|
| By Drug Type |
|
| By Route of Administration |
|
| By Pain Type |
|
| By Application |
|
| By Sales Channel |
|
| By Prescription Type |
|
| By Formulation |
|
| By End User |
|
Research Methodology
This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.
Secondary Research
The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.
Sources consulted during this phase included:
- Company annual reports, investor presentations, and press releases
- Industry white papers and certified publications
- Trade directories and market-recognized databases
- Articles from authoritative authors and reputable journals
- Gold and silver standard websites
Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.
Other key sources:
- Financial disclosures
- Industry associations and trade bodies
- News outlets and business magazines
- Academic journals and research studies
- Paid industry databases
Primary Research
To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.
On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.
On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.
Primary interviews provided critical inputs such as:
- Market size and revenue data
- Product and service breakdowns
- Market forecasts
- Regional and application-specific trends
Stakeholders consulted included:
- Leading OEM and solution providers
- Channel and distribution partners
- End users across various applications
- Independent consultants and industry specialists
Market Size Estimation and Data Triangulation
- Identifying Key Market Participants (Secondary Research)
- Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
- Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
- Extracting Earnings of Key Market Participants
- Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
- Methods: Earnings data can be gathered from:
- Publicly available financial reports (for listed companies).
- Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
- Annual reports and investor presentations of key players.
- Data Collation and Development of a Relevant Data Model
- Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
- Key KPIs: These could include:
- Market size, growth rate, and demand drivers.
- Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
- External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
- Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
- Scenario Analysis
- Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
- Types of Scenarios:
- Base Case: Based on current assumptions and historical data.
- Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
- Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.











